4 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 57 Item 1C. Cybersecurity 57 Item 2. Properties 58 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 60 Item 6. Reserved 60 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 61 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 67 Item 8. F...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-07-10 | 2025-04-30 | 0000950170-25-095011 | EDGAR | 67K words |
| 2024-07-11 | 2024-04-30 | 0000950170-24-082965 | EDGAR | — |
| 2023-07-10 | 2023-04-30 | 0000950170-23-032298 | EDGAR | — |
| 2022-07-07 | 2022-04-30 | 0000950170-22-012521 | EDGAR | — |
| 2021-07-13 | 2021-04-30 | 0001564590-21-036441 | EDGAR | — |
| 2020-07-01 | 2020-04-30 | 0001564590-20-031501 | EDGAR | — |
| 2019-07-16 | 2019-04-30 | 0001564590-19-025009 | EDGAR | — |
| 2018-07-30 | 2018-04-30 | 0001564590-18-017915 | EDGAR | — |
| 2017-07-27 | 2017-04-30 | 0001564590-17-014286 | EDGAR | — |
| 2016-03-30 | 2015-12-31 | 0001564590-16-015646 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-274442 | EDGAR | 18K words |
| 2025-09-11 | 2025-07-31 | 0001193125-25-200757 | EDGAR | — |
| 2025-03-12 | 2025-01-31 | 0000950170-25-037995 | EDGAR | — |
| 2024-12-05 | 2024-10-31 | 0000950170-24-133673 | EDGAR | — |
| 2024-09-05 | 2024-07-31 | 0000950170-24-103981 | EDGAR | — |
| 2024-03-11 | 2024-01-31 | 0000950170-24-029314 | EDGAR | — |
| 2023-12-07 | 2023-10-31 | 0000950170-23-068801 | EDGAR | — |
| 2023-09-07 | 2023-07-31 | 0000950170-23-047008 | EDGAR | — |
| 2023-03-09 | 2023-01-31 | 0000950170-23-007020 | EDGAR | — |
| 2022-12-08 | 2022-10-31 | 0000950170-22-026230 | EDGAR | — |
| 2022-09-08 | 2022-07-31 | 0000950170-22-018239 | EDGAR | — |
| 2022-03-10 | 2022-01-31 | 0000950170-22-003361 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001193125-26-122784 | EDGAR | 2K words |
| 2026-01-08 | 0001193125-26-007801 | EDGAR | — |
| 2025-11-10 | 0001193125-25-274405 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230906 | EDGAR | — |
| 2025-10-02 | 0001193125-25-227478 | EDGAR | — |
| 2025-09-29 | 0001193125-25-223262 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200742 | EDGAR | — |
| 2025-08-21 | 0001193125-25-185382 | EDGAR | — |
| 2025-07-10 | 0001193125-25-157382 | EDGAR | — |
| 2025-07-07 | 0001193125-25-155885 | EDGAR | — |
193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001348911 |
| Ticker | KALV |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.kalvista.com |
| Listed | 2015-04-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report